Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Puma Biotechnology (PBYI) Change in Intangibles (2023)

Puma Biotechnology (PBYI) has disclosed Change in Intangibles for 1 consecutive years, with $12.5 million as the latest value for Q1 2023.

  • For the quarter ending Q1 2023, Change in Intangibles changed N/A year-over-year to $12.5 million, compared with a TTM value of $12.5 million through Dec 2023, changed N/A, and an annual FY2023 reading of $12.5 million, changed N/A over the prior year.
  • Change in Intangibles was $12.5 million for Q1 2023 at Puma Biotechnology.
  • Across five years, Change in Intangibles topped out at $12.5 million in Q1 2023 and bottomed at $12.5 million in Q1 2023.